Shareholders Equity ratio Analysis of BiondVax Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointShareholders Equity of BVXV
Dec-22-6.50Very Poor Shareholders Equity | Dec-2123.43Not Good Shareholders Equity | Growth-127.76% |
Shareholders Equity Analysis of BiondVax Pharmaceuticals Ltd.
| Shareholders Equity Ratio of BVXV drastically fell by -127.76 % this year. |
| Shareholders Equity Ratio with value of 23.43 was highest in Year Dec-21 in last Five Years. |
| Shareholders Equity Ratio with value of -56.20 was lowest in Year Dec-19 in last Five Years. |
| Latest Shareholders Equity Ratio with value of -6.50 is Greater than Average Shareholders Equity of -18.88 in last five years. |
Other Shareholders Equity Related Info of BVXV that may interest you.
BiondVax Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| BVXV | 1.36 | 1.31 | 3.82 % | Biotechnology |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..
Shareholders Equity Related Ratios
| DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
| Very Low Stability Stock | |
FY - Historical Shareholders Equity of BiondVax Pharmaceuticals Ltd.
| Period | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|
| Shareholders Equity | -6.50 | 23.43 | -25.65 | -56.20 | -29.49 | 68.86 | 85.07 |
| Change | -127.76 % | 191.34 % | 54.37 % | -90.56 % | -142.83 % | -19.06 % | 4.76 % |
FY Chart of Shareholders Equity of BiondVax Pharmaceuticals Ltd.
Note : All Data Generated at the End of Trading Hours (EOD Data)